VEGFR-2 tyrosine kinase inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VEGFR-2 tyrosine kinase inhibitor (unspecified), covering 2006-11-07 to 2006-11-07. Get the full timeline:
Most recent: Clinical Trial Update: Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer [Phase 2]